Frontlight ResearchEarly access
Trial site
University of Fukui Hospital
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Myelodysplastic syndromes2 trials
- Acute myeloid leukaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Diffuse large B-cell lymphoma1 trial
- Heart failure1 trial
- Obesity1 trial
- Stroke1 trial
- Phase
- Phase 34 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Recruiting3 trials
- Completed1 trial
- Lead sponsor
- Incyte Biosciences Japan GK2 trials
- Eli Lilly and Company1 trial
- Institut de Recherches Internationales Servier1 trial
- Loxo Oncology, Inc.1 trial
- Medtronic Cardiac Rhythm and Heart Failure1 trial
- and 3 more
Running trials
Recruiting
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Recruiting
Active, not recruiting
Active, not recruiting
Special Use - Results Surveillance on Long-term Use With Wegovy®
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Myelodysplastic syndromes1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026